Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Behavioral: Assessment of impact of MS on cognition | - | - | - | - | [1] 13 13 |
| 2 | Behavioral: B-HIPE (Brief High Impact Preparatory Experience) | - | - | - | - | [1] 13 13 |
| 3 | Behavioral: Impact of four week coaching program on dietary habits | - | - | - | - | [1] 13 13 |
| 4 | Behavioral: Low-Impact Exercise Control | - | - | - | - | [1] 6 6 |
| 5 | Behavioral: TIP / IMPACT Plus Care Coordination | - | - | - | - | [3] 46 46, 96, 97 |
| 6 | Impact | - | - | - | - | [8] 6 6, 13, 46, 50, 53, 96, 97, 299 |
| 7 | Impact-Nutridrink | - | - | - | - | [1] 299 299 |
| 8 | Nutridrink-Impact | - | - | - | - | [1] 299 299 |
| 9 | Other: Acute response to high-impact exercise | - | - | - | - | [1] 96 96 |
| 10 | Other: High-impact exercise intervention | - | - | - | - | [1] 96 96 |
| 11 | Other: Impact of biotherapy on postoperative morbidity in ulcerative colitis | - | - | - | - | [1] 97 97 |
| 12 | Other: Impact Peptide 1.5 | - | - | - | - | [1] 299 299 |
| 13 | Other: Non Impact Aerobics | - | - | - | - | [1] 13 13 |
| 14 | Other: Rheumatoid Arthritis Impact of Disease questionnaire | - | - | - | - | [1] 46 46 |